Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effects of simultaneous administration of oral
aspirin and oral ketamine as a therapeutic for those with Treatment Resistant Depression.